Biggest News Aggregation in the World
๐Ÿ“ฐ Mini Symposium Session News

Mini Symposium Session News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mini Symposium Session. Real-time updates on events, politics, business and more.

MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RA

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn.--(BUSINESS WIRE)--MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of B...
United States New York United Kingdom Memorial Sloan Kettering Cancer Center Lusong Luo Saqib Islam

BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination with Mirdametinib, in P

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1b trial of BeiGeneโ€™s RAF dimer inhibitor, lifiraf...
United States United Kingdom Kevin Mannix Saqib Islam Lusong Luo Samantha Hilson Sandler

MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors at the American Association for Cancer Research Annual Meeting 2023

MapKure, LLC, BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1a/1b study of BGB-3245, an investigational, selective... | April 17, 2023
Memorial Sloan Kettering Cancer Center New York United States United Kingdom Lusong Luo Saqib Islam

BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination with Mirdametinib, in Patients with Advanced or Refractory Solid Tumors with MAPK Pathway Aberrations at the American Association for Cancer Research Annual Meeting 2023

BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1b trial of BeiGene’s RAF dimer inhibitor, lifirafenib, in... | April 17, 2023
United States United Kingdom Lusong Luo Saqib Islam European Commission American Association For Cancer Research

MapKure, SpringWorks and BeiGene Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors at the American Association for Cancer Research Annual Meeting 2023

STAMFORD, Conn. and BASEL, Switzerland and BEIJING and CAMBRIDGE, Mass. and SAN MATEO, Calif., April 17, 2023 -- MapKure, LLC, SpringWorks Therapeutics, Inc. , and BeiGene, Ltd. , today... | April 17, 2023
United States Memorial Sloan Kettering Cancer Center New York United Kingdom Lusong Luo Samantha Hilson Sandler

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

SpringWorks and BeiGene Present Clinical Data on Lifirafenib, in combination with Mirdametinib, in Patients with Advanced or Refractory Solid Tumors with MAPK Pathway Aberrations at the American Association for Cancer Research Annual Meeting 2023

STAMFORD, Conn. and BASEL, Switzerland and BEIJING and CAMBRIDGE, Mass., April 17, 2023 -- SpringWorks Therapeutics, Inc. , and BeiGene, Ltd. , today announced that they will present updated... | April 17, 2023
United States United Kingdom Kevin Mannix Saqib Islam Samantha Hilson Sandler Lusong Luo

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science